Robotic technology, first used by Mary Lanning Healthcare’s surgical services unit in June, has made lung cancer diagnoses much easier for community patients to accept.
Auris Health’s Monarch platform system is a less invasive alternative procedure that allows doctors to biopsy small, potentially cancerous lung abnormalities while the patient is sedated. And unlike bronchoscopic procedures performed by radiologists via computed tomography (CT) scans, this new treatment allows for deeper exploratory penetration into the lungs and smaller previously unreachable airways. while allowing access to the lungs while greatly reducing the risk of lung collapse during the process. .
First used in Nebraska, Monarch, the new technology has been dubbed a game changer for doctors facing lung cancer diagnoses.
Matthew Stritt, Ph.D., a pulmonologist at Hastings Pulmonary & Sleep Clinic, has teamed up with MLH Respiratory Therapy to offer robotic bronchoscopic treatments at MLH. Robots are used to look inside the lungs and take tissue samples for biopsies, diagnosing small, hard-to-reach lung nodules earlier and more accurately.
The new device will be used primarily for diagnosing lung cancer, but also for taking samples and diagnosing inflammatory lung disease, Stritt said.
Utilizing a controller that functions much like the X-Box controller, the robot gives physicians more precise control during the procedure, while allowing continuous bronchoscope vision throughout the procedure. Provides computer-based navigational imaging based on a 3D model of the patient. Lung anatomy.
These benefits raise the bar for what was once considered the gold standard of treatment to a whole new level, Stritt said.
“This has great advantages,” he said of robotic technology. “The more precise optics and stability are light years ahead of what it was before. This is difficult to do manually.
“Thanks to the robot, we can go deeper into the lungs more precisely, and we can also visualize it. ”
The technology incorporates the latest advances in robotics, software, data science, and endoscopy (entering the body through natural openings using tiny cameras and tools). Mary Lanning Healthcare was one of the first hospitals in the United States to utilize the platform and was recently approved by the US Food and Drug Administration (FDA).
“Until Sioux Falls, South Dakota, we’re the only ones in the area with this robot,” says Stritt. “It’s exciting.”
Sheri Trindle, MLH’s director of cardiopulmonary services, said the new device’s precision will allow physicians to identify potential areas of concern that were previously undetectable.
“Previously, doctors couldn’t get to the lesion,” says Triendl. “Robotic control allows us to examine lesions with improved reach and control.
“We are very excited to bring this kind of technology to the community. This is a step forward and I really feel that it will help in early diagnosis, which is very important in lung cancer.”
.
Comments
Post a Comment